Effect of Montelukast on the level of serum IL-4,TNF-α and IFN-γ in children with asthma
Shilai Li
Abstract
Shilai Li
Abstract
Objective: To investigate the effect of Montelukast on serum IL-4,TNF-α and IFN-γ in children with asthma,and to discuss the mechanism of preventing and controlling asthma.Methods: 180 children with acute attack asthma were randomly divided into treatment group and control group,90 cases for the same period check-up children served as the normal group.Based on the basic treatment as control group,the treatment group was also given Montelukast 5 mg/d bedtime orally,1 time per day for half a year.Results: The serum IL-4 and TNF-α of treatment group half a year after treatment were significantly decreased compared with those of the control group,the serum IFN-γ was significantly increased compared with that of control group,and the treatment group was similar with the normal group.Conclusion: Montelukast can reduce IL-4 and TNF-α levels,can increase IFN-γ level in children with asthma,and can also decrease inflammatory reaction,Montelukast can be used to treat asthma effectively.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the effect of Montelukast on serum IL-4,TNF-α and IFN-γ in children with asthma,and to discuss the mechanism of preventing and controlling asthma.Methods: 180 children with acute attack asthma were randomly divided into treatment group and control group,90 cases for the same period check-up children served as the normal group.Based on the basic treatment as control group,the treatment group was also given Montelukast 5 mg/d bedtime orally,1 time per day for half a year.Results: The serum IL-4 and TNF-α of treatment group half a year after treatment were significantly decreased compared with those of the control group,the serum IFN-γ was significantly increased compared with that of control group,and the treatment group was similar with the normal group.Conclusion: Montelukast can reduce IL-4 and TNF-α levels,can increase IFN-γ level in children with asthma,and can also decrease inflammatory reaction,Montelukast can be used to treat asthma effectively.
Key concepts: Montelukast, Medicine, Asthma, Bedtime, Internal medicine, Tumor necrosis factor alpha, Immunology, Gastroenterology